Feature

‘Rapid autopsy’ programs seek clues to cancer within hours of death


 


“These are mostly patients with metastatic cancer,” she said. “They’ve made their peace with the outcome long before.”

For some, the rapid autopsy is simply the final phase of the clinical trial.

“They want to do something not only for themselves, but also to help others,” Dr. Roychowdhury said.

That’s how Linda Boyed, 52, of Lewis Center, Ohio, sees it. Like Mr. Beck, she has bile duct cancer and is enrolled in a trial to treat it. The drugs are working now, but Ms. Boyed said she has agreed to a rapid autopsy after death so scientists can learn from her when they’re no longer effective.

Pages

Recommended Reading

MDedge Daily News: A call to push pause on a Medicare payment program
MDedge Hematology and Oncology
VIDEO: A treatment plan for medicine’s gender inequities
MDedge Hematology and Oncology
VIDEO: Fix physician burnout? You need more than yoga
MDedge Hematology and Oncology
MDedge Daily News: Bridging medicine’s gender gap
MDedge Hematology and Oncology
MDedge Daily News: Physician burnout needs more than yoga
MDedge Hematology and Oncology
Speakers at FDA advisory meetings have hidden conflicts
MDedge Hematology and Oncology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Hematology and Oncology
MDedge Daily News: Lupus is quietly killing young women
MDedge Hematology and Oncology
What’s in a name? Get ready for the feds’ Promoting Interoperability program
MDedge Hematology and Oncology
MDedge Daily News: How smartphones could battle oral cancer
MDedge Hematology and Oncology